Figma Reports Strong 2025 Revenue Growth and Strategic AI Expansion Amidst Significant Lock-Up Expiration
Summary
Figma reported strong 2025 revenue growth and strategic AI product expansion, but also a significant GAAP net loss due to IPO-related stock compensation. A large stock lock-up expiration is imminent, and new AI pricing models are set for March 2026.
Key Events
-
Strong 2025 Revenue Growth
Figma's revenue increased by 41% year-over-year, reaching $1.056 billion for the fiscal year ended December 31, 2025.
-
Significant Customer Expansion
Paid customers with over $100,000 in Annual Recurring Revenue (ARR) grew by 46% to 1,405, and Net Dollar Retention Rate improved to 136%.
-
Substantial GAAP Net Loss Driven by Stock Compensation
The company reported a GAAP net loss of $1.25 billion for 2025, primarily due to $975.7 million in one-time stock-based compensation expense related to IPO RSU vesting.
-
Strategic AI Product Launches and Acquisitions
Figma launched new AI-powered products like Figma Make and Figma Weave, and completed acquisitions (Weavy Inc., Payload CMS) to enhance its platform capabilities.
Analysis
Figma's annual report details robust top-line growth, with revenue increasing 41% year-over-year to over $1 billion in 2025, driven by a substantial rise in high-value customers and a strong Net Dollar Retention Rate. The company is aggressively expanding its product portfolio with new AI-powered offerings and strategic acquisitions, positioning itself for future innovation. However, significant non-cash stock-based compensation expenses related to its IPO led to a substantial GAAP net loss. Investors should note the upcoming expiration of a significant portion of Class A common stock lock-up on February 20, 2026, which could introduce selling pressure. The planned enforcement of new AI credit limits in March 2026 also presents a potential shift in monetization strategy.
At the time of this filing, FIG was trading at $27.57 on NYSE in the Technology sector, with a market capitalization of approximately $12B. The 52-week trading range was $19.85 to $142.92. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.